Natco Pharma Ltd.

991.20 +8.30 ▲0.8%

29 February 2024, 04:01:00 PM
Volume: 19,385

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.natcopharma.co.in
Market Cap 17,807.10 Cr.
Enterprise Value(EV) 17,272.67 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 71.34 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 13.94 Trailing Twelve Months Ending 2023-12
Industry PE 41.63 Trailing Twelve Months Ending 2023-12
Book Value / Share 307.42 Trailing Twelve Months Ending 2023-12
Price to Book Value 3.23 Calculated using Price: 994.20
Dividend Yield 0.55 Period Ending 2023-03
No. of Shares Subscribed 17.91 Cr. 179,109,870 Shares
FaceValue 2
About Natco Pharma Ltd.
Natco Pharma is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). It is also engaged in contract manufacturing business, whereby it undertake selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products. It has diversified into the business of crop health sciences to leverage is skills in organic chemistry.

Natco Pharma Ltd. Delivery

Delivered Qty
Traded Qty

Natco Pharma Ltd. Performance

1 Day
+0.84%
1 Week
-3.29%
1 Month
+13.96%
3 Month
+28.11%
6 Month
+10.48%
1 Year
+84.20%
2 Year
+14.19%
5 Year
+72.46%
10 Year
+486.93%

Natco Pharma Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 15.9 14.41 33.21 29.7 19.75 12.71 11.27 4.06 15.66
Return on Capital Employed (%) 14.89 17.49 39.21 35.28 23.71 14.82 13.99 4.86 18.06
Return on Assets (%) 9.69 9.58 23.43 23.05 16.02 10.3 9.43 3.43 13.29

Natco Pharma Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 846 1,296 1,649 3,072 3,489 3,774 4,122 4,264 4,874 5,294
Non Curr. Liab. 119 28 38 47 83 118 143 135 101 67
Curr. Liab. 414 493 627 592 729 685 526 710 683 878
Minority Int. 5 5 4 4 2 11 2
Equity & Liab. 1,384 1,822 2,318 3,715 4,303 4,588 4,792 5,109 5,657 6,239
Non Curr. Assets 901 985 1,230 1,584 1,956 2,262 2,447 2,622 2,657 2,889
Curr. Assets 483 837 1,087 2,131 2,347 2,326 2,345 2,487 3,000 3,350
Misc. Exp. not W/O
Total Assets 1,384 1,822 2,318 3,715 4,303 4,588 4,792 5,109 5,657 6,239

Natco Pharma Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 825 1,042 2,020 2,185 2,095 1,915 2,052 1,945 2,707 3,828
Other Income 15 10 14 40 130 107 106 99 129 115
Total Income 840 1,052 2,034 2,225 2,225 2,022 2,158 2,044 2,836 3,944
Total Expenditure -620 -777 -1,337 -1,256 -1,300 -1,332 -1,448 -1,681 -1,795 -2,235
PBIDT 221 275 697 969 925 690 710 363 1,040 1,708
Interest -32 -23 -19 -15 -19 -22 -13 -18 -15 -16
Depreciation -47 -51 -54 -66 -81 -100 -117 -143 -164 -172
Taxation -2 -48 -140 -192 -182 -111 -137 -32 -147 -243
Exceptional Items -15
PAT 125 154 485 695 642 458 442 170 715 1,278
Minority Interest 4 1 1 1 2 3 -2
Share Associate
Other Related Items
Consolidated Net Profit 135 157 486 696 644 461 441 170 715 1,278
Adjusted EPS 8 9 28 38 35 25 24 9 39 71

Natco Pharma Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 144 93 112 346 464 669 417 299 47 849
Cash Fr. Inv. -109 -115 -176 -299 -1,116 -612 -167 -103 -5 -477
Cash Fr. Finan. -35 29 154 -48 651 -51 -251 -186 35 -363
Net Change 0 7 91 -1 -1 6 -1 10 76 9
Cash & Cash Eqvt 10 12 -74 24 22 28 20 26 111 132

Natco Pharma Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 48.86 48.81 48.80 48.80 48.82 48.84 49.76 49.71 49.71
Public 51.14 51.19 51.20 51.20 51.18 51.16 50.24 50.29 50.29
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Natco Pharma Ltd. Announcements

Thu, 29 Feb 2024
Announcement under Regulation 30 (LODR)-Change in Management
Resignation & Appointment of Senior Management Personnel
Mon, 26 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Newspaper Publication of Postal Ballot Notice
Fri, 23 Feb 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor meet on February 28 2024

Natco Pharma Ltd. Technical Scans

Thu, 29 Feb 2024
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Month High Close Above Last Month High
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 1 Year High Increase in 1 Year

Natco Pharma Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 378,183.18 1,577.95 +0.3%
Cipla Ltd. 119,792.84 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. 107,100.71 6,424.25 -0.1%
Zydus Lifesciences Ltd. 95,405.30 941.90 +1.0%
Divi's Laboratories Ltd. 92,624.64 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. 90,256.63 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. 87,793.47 6,105.90 -3.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-12 32.31 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.49 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.08 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 66.98 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.41 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 111.23 6,105.90 -3.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.06 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-12 4.63 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.99 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.91 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.11 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.62 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.00 6,105.90 -3.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,105.90 -3.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,105.90 -3.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,489.10 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,666.80 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,105.90 -3.9%

Natco Pharma Ltd. FAQ's

What is Natco Pharma share price?

Can I buy Natco Pharma shares now?

What is the Dividend Yield of Natco Pharma?

What is the Market Cap of Natco Pharma?

What are the key metrics to analyse Natco Pharma?

What is the 52 Week High and Low of Natco Pharma?

What is the trend of Natco Pharma share price?